Related Experiment Video
Updated: May 7, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis
Stephanie Bayers1, Stanford T Shulman, Amy S Paller
1Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Abstract:
Kawasaki disease, or mucocutaneous lymph node syndrome, most commonly affects children between 6 months and 5 years of age. Approximately 90% of patients have mucocutaneous manifestations. This article will focus on the epidemiology of Kawasaki disease in the United States as it relates to other countries, the diagnosis of Kawasaki disease, its clinical course, and the currently accepted theories of pathogenesis. A particular focus is given to the various dermatologic manifestations that may occur.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Introduction to Language of Pathophysiology l
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Graves Disease II: Pathophysiology
Myocarditis II: Clinical Features and Diagnostic Tests
